Design and rationale of the INSYTE study: a randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal …
E Scorletti, PR Afolabi, EA Miles, DE Smith… - Contemporary clinical …, 2018 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of fat-related
conditions ranging from simple fatty liver, to non-alcoholic steatohepatitis (NASH), fibrosis …
conditions ranging from simple fatty liver, to non-alcoholic steatohepatitis (NASH), fibrosis …
Synbiotics alter fecal microbiomes, but not liver fat or fibrosis, in a randomized trial of patients with nonalcoholic fatty liver disease
E Scorletti, PR Afolabi, EA Miles, DE Smith… - Gastroenterology, 2020 - Elsevier
Background & Aims Dysbiosis of the intestinal microbiota has been associated with
nonalcoholic fatty liver disease (NAFLD). We investigated whether administration of a …
nonalcoholic fatty liver disease (NAFLD). We investigated whether administration of a …
[HTML][HTML] Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: A systematic review, meta-analysis, and meta-regression
SR Sharpton, B Maraj, E Harding-Theobald… - The American journal of …, 2019 - Elsevier
Background Preclinical evidence suggests that modulation of the gut microbiome could
represent a new therapeutic target in nonalcoholic fatty liver disease (NAFLD). Objectives …
represent a new therapeutic target in nonalcoholic fatty liver disease (NAFLD). Objectives …
Use of probiotics, prebiotics, and synbiotics in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
Abstract Background and Aim Patients with non‐alcoholic fatty liver disease (NAFLD) exhibit
compositional changes in their gut microbiome, which represents a potential therapeutic …
compositional changes in their gut microbiome, which represents a potential therapeutic …
Efficacy of probiotics and synbiotics in patients with nonalcoholic fatty liver disease: a meta-analysis
L Liu, P Li, Y Liu, Y Zhang - Digestive diseases and sciences, 2019 - Springer
Abstract Background and Aim Extensive epidemiological evidence suggests that
nonalcoholic fatty liver disease (NAFLD) is the primary chronic liver disease worldwide …
nonalcoholic fatty liver disease (NAFLD) is the primary chronic liver disease worldwide …
[HTML][HTML] Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol
JE Lambert, JA Parnell, B Eksteen, M Raman… - BMC …, 2015 - Springer
Background Evidence for the role of the gut microbiome in the pathogenesis of non-
alcoholic fatty liver disease (NAFLD) is emerging. Strategies to manipulate the gut …
alcoholic fatty liver disease (NAFLD) is emerging. Strategies to manipulate the gut …
Can bugs be drugs? The potential of probiotics and prebiotics as treatment for non‐alcoholic fatty liver disease
N Koopman, A Molinaro, M Nieuwdorp… - Alimentary …, 2019 - Wiley Online Library
Background Non‐alcoholic fatty liver disease (NAFLD) has become the most common
chronic liver condition. A major current research effort is ongoing to find potential strategies …
chronic liver condition. A major current research effort is ongoing to find potential strategies …
[HTML][HTML] Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease
SM Ferolla, GN de Almeida Armiliato… - World journal of …, 2015 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is currently recognized as one of the most common
causes of chronic liver disease. It involves a spectrum of conditions that include pure …
causes of chronic liver disease. It involves a spectrum of conditions that include pure …
[HTML][HTML] The therapeutic implications of the gut microbiome and probiotics in patients with NAFLD
Recent breakthrough in our understanding pertaining to the pathogenesis of nonalcoholic
fatty liver disease (NAFLD) has pointed to dysregulation or derangement of the gut …
fatty liver disease (NAFLD) has pointed to dysregulation or derangement of the gut …
emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications
S Jayakumar, R Loomba - Alimentary pharmacology & …, 2019 - Wiley Online Library
Background Nonalcoholic fatty liver disease (NAFLD) is a prevalent disorder associated with
obesity and diabetes. Few treatment options are effective for patients with NAFLD, but …
obesity and diabetes. Few treatment options are effective for patients with NAFLD, but …